Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance
The mechanisms of PARP inhibitor (PARPi) resistance are poorly understood. Here the authors employ a CRISPR mutagenesis approach to identify PARP1 mutants causing PARPi resistance and find that PARP1 mutations are tolerated in BRCA1 mutated cells, suggesting alternative resistance mechanisms.
Guardado en:
Autores principales: | Stephen J. Pettitt, Dragomir B. Krastev, Inger Brandsma, Amy Dréan, Feifei Song, Radoslav Aleksandrov, Maria I. Harrell, Malini Menon, Rachel Brough, James Campbell, Jessica Frankum, Michael Ranes, Helen N. Pemberton, Rumana Rafiq, Kerry Fenwick, Amanda Swain, Sebastian Guettler, Jung-Min Lee, Elizabeth M. Swisher, Stoyno Stoynov, Kosuke Yusa, Alan Ashworth, Christopher J. Lord |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1eb977c74fb546b0a7321e49be5d0643 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A genetic screen using the PiggyBac transposon in haploid cells identifies Parp1 as a mediator of olaparib toxicity.
por: Stephen J Pettitt, et al.
Publicado: (2013) -
Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targets
por: Dragomir B. Krastev, et al.
Publicado: (2018) -
Differential regulation of breast cancer bone metastasis by PARP1 and PARP2
por: Hao Zuo, et al.
Publicado: (2020) -
Serine-linked PARP1 auto-modification controls PARP inhibitor response
por: Evgeniia Prokhorova, et al.
Publicado: (2021) -
Dual function of HPF1 in the modulation of PARP1 and PARP2 activities
por: Tatyana A. Kurgina, et al.
Publicado: (2021)